WALTHAM, Mass., Sept. 29, 2017 /PRNewswire/ -- Alere Inc.
(NYSE: ALR) (the "Company"), a global leader in rapid diagnostic
tests, today announced the U.S. Department of Justice (the "DOJ")
has closed the previously announced investigation into, among other
things, sales, sales practices and dealings with certain third
parties, without taking any action against Alere. The DOJ
investigation primarily involved matters occurring at foreign
subsidiaries previously acquired by the Company.
Alere issued the following statement:
We are pleased that this matter has been closed with no action
taken against Alere.
About Alere
Alere believes that when diagnosing and monitoring health
conditions, Knowing now matters™. Alere delivers reliable and
actionable information by providing rapid diagnostic tests,
enhancing clinical and economic healthcare outcomes globally.
Headquartered in Waltham, Mass.,
Alere focuses on rapid diagnostics for cardiometabolic disease,
infectious disease and toxicology.
For more information on Alere, please visit www.alere.com.
View original
content:http://www.prnewswire.com/news-releases/alere-announces-the-us-department-of-justice-closes-investigation-300528360.html
SOURCE Alere Inc.